Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Angi Inc (ANGI) Price & Performance

AbCellera Biologics IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Angi Inc — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while Angi Inc trades at $4.5 (market cap $182.30M). The key difference: AbCellera Biologics Inc is far larger — about 16.4× Angi Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Angi Inc nearer its low. Which is the better fit depends on your goals.

ABCLANGI
Market Cap
$2.99B$182.30M
Sector
HealthMedia
52-Week High
$9.76$18.46
52-Week Low
$2.78$4.49
Enterprise Value
$2.58B$392.07M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Angi Inc

Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. It has two geographical segments namely North America (the United States and Canada), which primarily includes the operations HomeAdvisor, Angie's List, Handy, mHelpDesk, HomeStars, and Fixd Repair

Read more on ANGI